Catalyst
Slingshot members are tracking this event:
Amgen (AMGN) Phase 3 ENDEAVOR Data Comparing Kyprolis to Takeada's (TKPYY) Velcade in Relapsed/Refractory Multiple Myeloma
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 28, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3, Endeavor, Kyprolis, Velcade, Relapsed/refractory Multiple Myeloma
